CPM
AGN

Crescent Park Management’s Allergan plc AGN Stock Holding History

Crescent Park Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-129,053
Closed -$21.6M – 28
2019
Q2 		$21.6M Sell
129,053
-44,700
-26% -$6.19M 3.93% 13
2019
Q1 		$25.4M Buy
+173,753
New +$25.2M 4.46% 12
2018
Q4 		– Sell
-138,078
Closed -$26.3M – 21
2018
Q3 		$26.3M Hold
138,078
– – 4.96% 10
2018
Q2 		$23M Buy
138,078
+11,699
+9% +$1.88M 4.52% 11
2018
Q1 		$21.3M Buy
126,379
+41,514
+49% +$6.96M 4.64% 10
2017
Q4 		$13.9M Buy
84,865
+33,462
+65% +$6M 2.69% 16
2017
Q3 		$10.5M Buy
+51,403
New +$12M 1.93% 18
2016
Q2 		– Sell
-54,236
Closed -$14.5M – 21
2016
Q1 		$14.5M Buy
+54,236
New +$15.5M 2.96% 12

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Crescent Park Management's AGN Position: Q3 2019 in Review

Crescent Park Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 129,053 shares — an estimated $21.6M sold.

Crescent Park Management first reported a position in AGN in Q1 2016 and held it in 8 quarters. The position peaked at $26.3M in Q3 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Crescent Park Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Crescent Park Management sold 129,053 Allergan plc shares in Q3 2019, an estimated $21.6M.
  • Crescent Park Management first reported a position in Allergan plc in Q1 2016 and held it in 8 quarters.
  • Crescent Park Management's Allergan plc position peaked at $26.3M in Q3 2018.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Crescent Park Management's 13F filing for Q3 2019, filed 13 Nov 2019.